Chaturvedi Shushma, Bertino Joseph R
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Methods Mol Biol. 2019;1866:1-12. doi: 10.1007/978-1-4939-8796-2_1.
Cancer cells require exogenous methionine for survival and therefore methionine restriction is a promising avenue for treatment. The basis for methionine dependence in cancer cells is still not entirely clear. While the lack of the methionine salvage enzyme methylthioadenosine phosphorylase (MTAP) is associated with methionine auxotrophy in cancer cells, there are other causes for tumors to require exogenous methionine. Restricting methionine by diet or by enzyme depletion, alone or in combination with certain chemotherapeutics, is a promising antitumor strategy.
癌细胞需要外源性甲硫氨酸来维持生存,因此限制甲硫氨酸是一种很有前景的治疗途径。癌细胞对甲硫氨酸依赖的基础仍不完全清楚。虽然缺乏甲硫氨酸补救酶甲基硫代腺苷磷酸化酶(MTAP)与癌细胞的甲硫氨酸营养缺陷有关,但肿瘤需要外源性甲硫氨酸还有其他原因。通过饮食或酶消耗来限制甲硫氨酸,单独或与某些化疗药物联合使用,是一种很有前景的抗肿瘤策略。